Porterhouse Medical Group

What Porterhouse Medical Group does

Porterhouse Medical Group is a privately held UK-headquartered medical communications agency, founded in 2001 and operating as a wholly-owned portfolio company of the SCIRIS Group (formerly imc Group) since August 2020. The firm delivers scientific and medical communications, publication planning, behavioural science insights, real-world evidence generation, medical advisory services, and live and virtual event management to pharmaceutical, biotechnology and diagnostic clients globally. Its core platforms include the Porterhouse Intelligence Hub (an in-house strategic intelligence platform supporting evidence-based communications) and the Porterhouse Behaviour Promoter Score (a proprietary behavioural science measurement framework), with Porterhouse Insights operating as a dedicated sub-brand focused on behavioural science research and real-world evidence consultancy. Service delivery is anchored by an in-house Medical Advisory Group staffed by medical doctors and by ISMPP-certified publication professionals.

The business operates a B2B professional services model, monetising through quote-based retainers and project engagements with biopharmaceutical, biotechnology and diagnostic companies rather than through disclosed pricing or self-serve channels. Go-to-market is enterprise field sales with dedicated new-business and career contacts, complemented by thought-leadership content marketing (LinkedIn, X, Instagram, Facebook, blog), disease-awareness editorial, and industry-event participation, notably as keynote sponsor at ISMPP 2026. The firm serves clients from four offices — Reading (UK HQ), London, Nottingham (MediCity / Boots HQ), and Holmdel, New Jersey (Porterhouse Medical US, the dedicated US sub-brand). Certifications include Gold Investors in People (July 2019), ISO 14001, Cyber Essentials Plus, and ICO/GDPR registration, supporting positioning as a compliance-ready vendor for regulated biopharma procurement.

Name

Porterhouse Medical Group

Legal name

Porterhouse Medical Group Ltd

Website

https://porterhousemedical.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Porterhouse Medical Group is a UK-headquartered medical communications agency serving global pharmaceutical, biotechnology and diagnostic clients with publication planning, scientific communications, behavioural science insights and real-world evidence services across offices in the UK and US.

Ownership category

akta.pro rank

Product category

Medical Communications Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

akta.pro secondary industry

Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

• Medical communications
• Publication planning
• Scientific communications
• Behavioural science insights
• Pharmaceutical consultancy

Headquarters

HQ city

Reading

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Strategic Scientific Communications Services: Full-service medical communications agency providing scientific and medical communications to pharmaceutical, biotech and diagnostic companies. Services span strategy, science, creativity, publication planning, live and virtual events, and medical advisory services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Porterhouse Medical Group is a global strategic scientific communications agency providing insight-driven medical communications, publication planning, behavioural science research, real-world evidence generation, medical advisory services, and live/virtual event management to biopharmaceutical, biotechnology, and diagnostic clients. Its sub-brand Porterhouse Insights combines behavioural science with real-world evidence, while Porterhouse Medical US delivers the same suite of services to US-based clients.

Product overview

Porterhouse Medical Group operates as a unified platform-plus-services model consisting of its core agency brand (Porterhouse Medical) supplemented by specialized sub-brands including Porterhouse Insights (strategic research and behavioural science consultancy) and Porterhouse Medical US (US-based operations). The company offers integrated communications services spanning publication planning, scientific and medical communications, strategic insights, behavioural science applications (Porterhouse Behaviour Promoter Score), medical advisory services, and live/virtual event management. The portfolio is unified by a hybrid approach combining science, insights, and creativity to deliver insight-driven solutions that support product commercialisation and address unmet health needs.

Differentiator

Problem solved

Functional benefit

Brands

• Porterhouse Insights: A global strategic research, insight and evidence consultancy for biopharmaceutical and biotech companies that focuses on behavioral science and real-world evidence.

Products and services

• Porterhouse Medical (Core Agency) Global strategic scientific communications agency delivering insight-driven medical communications, publication planning, strategic research, and event management for pharmaceutical, biotech, and diagnostic clients across the product lifecycle.
• Porterhouse Insights Global strategic research, insight and evidence consultancy for biopharmaceutical and biotech companies that combines behavioural science with real-world evidence to generate actionable insights across the product lifecycle.
• Porterhouse Medical US US-based operation offering Porterhouse's network of experts and suite of scientific and medical communications services to US-based pharmaceutical, biomedical, and diagnostic clients.
• Publication Planning Services Medical publications expertise including strategic publication planning, manuscript development, and support for congress presentations and scientific meetings.
• Medical Advisory Group Specialist team of in-house medical doctors providing clinical experience and real-world insights to enhance scientific communications programmes for biopharmaceutical and biotech clients.
• Live & Virtual Events Event management services for scientific meetings, congress support, and both in-person and virtual educational events for biopharmaceutical and biotech clients.
• Strategy Services Strategic communications consulting helping biopharmaceutical, biotech, and diagnostic clients develop effective messaging and stakeholder engagement strategies.

Quantifiable outcome

• ISMPP 2026 keynote sponsorship demonstrates leadership in evolving publication industry standards and practices

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• SCIRIS GroupparentOthersPorterhouse Medical Group is part of the SCIRIS Group, a healthcare communications and medical insights network. SCIRIS acquired Porterhouse Medical Group in August 2020 as part of its expansion strategy in the medical communications sector.

Scale indicators2 records

Recent moves9 records

Expansion highlights6 records

Others

• Publicis Health:

Direct peers

• OPEN Health: UK-founded medical communications and HEOR consultancy serving pharma clients across publication planning, medical affairs, and patient engagement. Directly comparable service portfolio and biopharma client base.
• Fishawack Health: Global medical communications agency headquartered in the UK with US operations, offering scientific communications, publications, and strategic consulting to biopharma. Highly comparable in size, services, and geographic model to Porterhouse Medical.

Broad incumbents

• CMC Connect (IPG Health): Part of IPG Health's medical communications network; Michael Tague, now Porterhouse US President, previously spent 8 years here. Significantly larger scale but operates the same scientific communications and publication planning model for biopharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/PorterhouseMed
• Facebookfacebook.com/PorterhouseMedical
• LinkedInlinkedin.com/company/porterhouse-medical
• Instagraminstagram.com/porterhousemedicalgroup

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Porterhouse Medical Group